The IMPACT Trial: Single Inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients with COPD. Results on Cardiovascular Safety

D. A. Lipson, G. Criner, M. T. Dransfield, D. M. G. Halpin, M. K. Han, C. E. Jones, S. Kilbride, P. Lange, D. A. Lomas, F. J. Martinez, S. Pascoe, D. Singh, R. A. Wise

Original languageEnglish
Article numberB45
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume199
Issue numberA3334
ISSN1073-449X
Publication statusPublished - 2019

Cite this